Related Experiment Video
Updated: May 10, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
[Update of the treatment of multiple sclerosis]
1Department of Neurology, Kinki University School of Medicine.
Abstract:
Recently a lot of new therapeutic agents for multiple sclerosis (MS) have been developed and the guidelines for treatment have revised. In particular, fingolimod which was placed on the market at the end of 2011 has been focused because of the first oral drug for MS. Novel therapeutic agents for MS can be divided into the following three patterns: (1) newly developed drugs, (2) the induction of drugs that are already used in the U.S. and Europe, (3) expanded indications for drugs that have been approved in other diseases. The new drug is in demand for stronger therapeutic effect and more convenient drug administration.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment
Treatment Resistant Cancers
Rheumatic Heart Disease III: Medical Management

